Enveric Biosciences, Inc. Quarterly Interest Expense in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Enveric Biosciences, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2023.
  • Enveric Biosciences, Inc. Interest Expense for the quarter ending March 31, 2023 was $11.000.
  • Enveric Biosciences, Inc. Interest Expense for the twelve months ending March 31, 2023 was $1.12K.
  • Enveric Biosciences, Inc. annual Interest Expense for 2022 was $5.25K, a 49.1% decline from 2021.
  • Enveric Biosciences, Inc. annual Interest Expense for 2021 was $10.3K, a 97.7% decline from 2020.
  • Enveric Biosciences, Inc. annual Interest Expense for 2020 was $445K, a 444% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.12K $11.00* -$4.13K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $5.25K $135 Oct 1, 2022 Dec 31, 2022 10-K/A 2023-06-09
Q3 2022 $308 -$62 -16.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $668 -$4.15K -86.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $4.14K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $370 -$75.1K -99.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $4.82K -$46.1K -90.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q4 2020 $445K $57.1K +$527K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$81.9K $75.5K -$177K -70.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $95.3K $50.9K -$106K -67.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $201K $262K +$119K +83.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $81.8K -$470K -$616K -422% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 $698K $253K +$62.3K +32.7% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $635K $157K -$25.9K -14.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $661K $143K -$68.6K -32.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $730K $146K -$41.1K -22% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 $771K $190K +$57.4K +43.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $714K $183K +$18.2K +11.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $695K $211K +$120K +133% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $575K $187K +$111K +145% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 $465K $133K -$157K -54.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $622K $164K -$106K -39.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $728K $90.8K -$22.9K -20.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $751K $76.4K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $290K +$228K +368% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $271K +$245K +959% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $114K Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-05-15
Q3 2015 $62.1K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $25.5K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q2 2011 $0 $0 Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-02
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.